Nasdaq: KYMR
Kymera Therapeutics insiders
The officers, directors and 10% owners of Kymera Therapeutics, Inc. who hold the most stock, valued at the live KYMR price.
$119.39
KYMR today −$1.7M (−1.44%)
Market closed. Prices as of Nov 19, 4:04 PM ET
- Ranked insiders
- 13
- Their KYMR stock
- $3.01B
- Market value
- $10.19B
- Held by ranked insiders
- 29.5%
Insiders by value of KYMR holdings
SEC ownership page| # | Insider | Role | Shares | Value | Of company | Overall rank |
|---|---|---|---|---|---|---|
| 1 | Atlas Venture Fund X, L.P. | 10% owner | 6,586,996 | $786M | 7.72% | Corporate |
| 2 | Atlas Venture Associates Opportunity I, L.P. | 10% owner | 6,366,980 | $760M | 7.46% | Corporate |
| 3 | Atlas Venture Opportunity Fund I, L.P. | 10% owner | 5,858,262 | $699M | 6.86% | Corporate |
| 4 | Atlas Venture Associates Opportunity I, LLC | 10% owner | 4,676,075 | $558M | 5.48% | Corporate |
| 5 | Nello Mainolfi | Chief Executive Officer | 666,568 | $79.6M | 0.78% | 1805th |
| 6 | Biotechnology Value Trading Fund OS LP | Director | 484,057 | $57.8M | 0.57% | Corporate |
| 7 | Bruce N. Jacobs | Chief Financial Officer | 244,883 | $29.2M | 0.29% | 3859th |
| 8 | Jared Gollob | Chief Medical Officer | 117,134 | $14.0M | 0.14% | 6806th |
| 9 | Ellen Chiniara | Chief Legal Officer | 80,085 | $9.6M | <0.1% | 9086th |
| 10 | Brian Adams | Chief Legal Officer | 50,254 | $6.0M | <0.1% | 7698th |
| 11 | Noah Goodman | Chief Business Officer | 47,179 | $5.6M | <0.1% | 13327th |
| 12 | Jeremy G. Chadwick | Chief Operating Officer | 44,018 | $5.3M | <0.1% | 13974th |
| 13 | Pamela Esposito | Director | 1,000 | $119K | <0.1% | 14098th |
Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for Kymera Therapeutics; see each profile for the filing.